March 12, 2021 — A new review suggests that blood vessel damage and impaired oxygen delivery related to COVID-19 play a role in mood changes and cognitive difficulties that people with the disease face during illness and recovery. The review was published in Physiological Reports in February.[1] The article offers insights into the reason why some ling-hauler COVID patients have persistent symptoms months after their infections.

March 12, 2021 — Cardinal Health today announced that it is selling its Cordis cardiology and endovascular business to Hellman & Friedman (H&F) for approximately $1 billion. 

An example of intra-cardiac echo (ICE) imaging from Siemens Healthineers showing color flow Doppler with severe valve regurgitation. ICE has seen wider use in transcatheter structural heart  procedures because, unlike TEE, it can be used without deeper sedation of anesthesia.

Intra-cardiac Echocardiography (ICE) uses catheter-based cardiac ultrasound array to image anatomy and devices inside the heart to help guide procedures.
The Teleflex Manta large-bore vascular closure device can seal holes between 12 and 25 French.

While many cardiac and vascular procedures have largely moved to minimally invasive techniques, the size of these transcatheter devices has required larger arterial access introducer sheaths, leading to increases in vascular and bleeding complications. Large bore devices are generally considered anything 10 French and bigger. This growth in large bore interventions has led to a new demand for large-bore vascular closure devices.

March 8, 2021 — In a new study from Shiley Eye Institute at UC San Diego Health, researchers have identified a potential new marker that shows cardiovascular disease may be present in a patient using an optical coherence tomography (OCT) scan, a non-invasive diagnostic tool commonly used in ophthalmology and optometry clinics to create images of the retina. The finding suggests it may be possible to detect heart disease during an eye examination.

AMERICAN COLLEGE OF CARDIOLOGY (ACC) Late-breaking clinical trial study presentations at ACC.21. @ACC21 @ACC2021

The latest cardiology practice-changing scientific breakthrough, late-breaking study presentations have been announced for the 2021 American College of Cardiology (ACC) meeting. Top experts will debate and discuss the outcomes of the hottest trials at ACC.21 and explain how it all fits into current cardiology practice.

March 8, 2021 — University of Kansas Health System Cardiologist Ashley Simmons, M.D., knew there could and should be a better way to measure female heart function. She had seen countless women balk at the uncomfortable testing that requires patients to go bra-less.

March 3, 2021 — Medtronic announced new results from the landmark REVERSE trial, evaluating outcomes of cardiac resynchronization therapy (CRT) for patients with mild heart failure (HF).

March 3, 2021 — Impulse Dynamics recently announced that DEKRA Certification B.V., a global regulatory organization, approved labeling for the Optimizer Smart device for conditional full-body magnetic resonance imaging (MRI) scans utilizing 1.5 Tesla scanners in the European Union (EU).

March 3, 2021 — AliveCor recently announced a new collaboration with AstraZeneca to research new disease management solutions in cardiovascular, renal and metabolism (CVRM) therapeutic areas. The collaboration will translate AliveCor’s potassium detection technology and science, which enables potassium measurement outside of blood draws, into real-world disease management applications and solutions.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now